Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 21 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT05139017
- Conditions
- DLBCL, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175) Glendale, Arizona, United States
- Beverly Hills Cancer Center ( Site 0184) Beverly Hills, California, United States
- Bass Medical Group ( Site 0166) Walnut Creek, California, United States
- Innovative Clinical Research Institute ( Site 0122) Whittier, California, United States
Recruiting
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
NCT04002947
- Conditions
- DLBCL, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Recruiting
SynKIR-310 for Relapsed/Refractory B-NHL
NCT06544265
- Conditions
- Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +54 more
- Locations
-
- Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute Denver, Colorado, United States
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- The University of Kansas Cancer Center Fairway, Kansas, United States
- Rutgers Cancer Institute New Brunswick, New Jersey, United States
NCT04512716
- Conditions
- B ALL, B-ALL, DLBCL, +25 more
- Locations
-
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
Recruiting
Study of SGR-1505 in Mature B-Cell Neoplasms
NCT05544019
- Conditions
- ALK-Positive Large B-Cell Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +66 more
- Locations
-
- Banner Health - MD Anderson Cancer Center Gilbert, Arizona, United States
- Christiana Care Hospital - Helen F Graham Cancer Center Newark, Delaware, United States
- Napa Research Pompano Beach, Florida, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT03758989
- Conditions
- DLBCL
- Locations
-
- University of Rochester Rochester, New York, United States
Recruiting
A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)
NCT05487170
- Conditions
- Advanced Solid Tumor, DLBCL
- Locations
-
- Emory University Winship Cancer Institute Atlanta, Georgia, United States
- Norton Cancer Institute Louisville, Kentucky, United States
- Weill Cornell - NY Presbyterian Hospital New York, United States
- Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
Enrolling by Invitation
Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells
NCT03628612
- Conditions
- ALL, Adult and Pediatric, Blood Protein Disorders, Cardiovascular Diseases, +20 more
- Locations
-
- University of Miami Miami, Florida, United States
- Washington University in St. Louis St Louis, Missouri, United States
- St David's South Austin Medical Center Austin, Texas, United States
- Queen Elizabeth University Hospital Glasgow, United Kingdom
NCT05653271
- Conditions
- B-cell Lymphoma, Burkitt Lymphoma, DLBCL, +23 more
- Locations
-
- AdventHealth Orlando Orlando, Florida, United States
- Emory University Atlanta, Georgia, United States
- Indiana University Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
- Norton Cancer Institute Louisville, Kentucky, United States
NCT04088890
- Conditions
- B-ALL, B-cell Non Hodgkin Lymphoma, DLBCL, +11 more
- Locations
-
- Stanford Medical Center Stanford, California, United States
NCT04566978
- Conditions
- DLBCL, Large B-cell Lymphoma
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
NCT03997968
- Conditions
- Adnexal Diseases, Blood Protein Disorders, Breast Cancer, +68 more
- Locations
-
- University of California San Francisco San Francisco, California, United States
- Stanford Comprehensive Cancer Center Stanford, California, United States
- Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
- Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
NCT05233033
- Conditions
- DLBCL, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
- Norton Cancer Institute Louisville, Kentucky, United States
- Henry Ford Health System Detroit, Michigan, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT03527147
- Conditions
- DLBCL, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Research Site Los Angeles, California, United States
- Research Site Sarasota, Florida, United States
- Research Site Atlanta, Georgia, United States
- Research Site New Orleans, Louisiana, United States
NCT01563302
- Conditions
- Advanced Cancers, DLBCL, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- Mayo Clinic Arizona Scottsdale, Arizona, United States
- Moores UC San Diego Cancer Center La Jolla, California, United States
- Yale Cancer Center New Haven, Connecticut, United States
- Blood and Marrow Transplant Group of Georgia at Northside Hospital Atlanta, Georgia, United States
Active, Not Recruiting
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037
- Conditions
- Aggressive B-cell Non-Hodgkin Lymphoma (aNHL), Chronic Disease, DLBCL, +26 more
- Locations
-
- Arizona Mayo Clinic Phoenix, Arizona, United States
- University of California at San Francisco San Francisco, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
Active, Not Recruiting
P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies
NCT06014762
- Conditions
- DLBCL, DLBCL - Diffuse Large B Cell Lymphoma, DLBCL Arising From Follicular Lymphoma, +21 more
- Locations
-
- Loma Linda University Cancer Center Loma Linda, California, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- Advent Health Orlando Orlando, Florida, United States
- Indiana University Indianapolis, Indiana, United States
Active, Not Recruiting
Study of Oral MRT-2359 in Selected Cancer Patients
NCT05546268
- Conditions
- Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +38 more
- Locations
-
- Honor Health Research Institute Scottsdale, Arizona, United States
- University of California San Diego San Diego, California, United States
- Yale University New Haven, Connecticut, United States
- University of Kansas Cancer Center Lawrence, Kansas, United States
Active, Not Recruiting
Split-Dose R-CHOP for Older Adults With DLBCL
NCT03943901
- Conditions
- Cancer, DLBCL, Diffuse Large B Cell Lymphoma, +11 more
- Locations
-
- University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States
Active, Not Recruiting
A Study of Polatuzumab Vedotin, Rituximab and Dose Attenuated CHP in Older Patients With DLBCL
NCT04594798
- Conditions
- DLBCL, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- University of Rochester Rochester, New York, United States